Jilin Province Great Great Pharmaceutical Co. LTD

Jilin Province Broadwell Pharmaceutical Co., LTD. Welcome you!

Service hotline:+86-431-85639055

博大伟业

Company Profile

President Speech

COMPANY CULTURE

development path

Brand Honors

TEAM MANAGEMENT

COMPANY

PROFILE

Jilin Province Great Great Pharmaceutical Co. LTD

Jilin Broadwell Pharmaceutical Co., Ltd. is a biochemical pharmaceutical limited company founded in April, 2010, which takes maintaining the human health as the philosophy, takes widely collecting scientific essence, and creating permanent undertaking as core values, and adopts a sustainable development strategy depending on two R&D platforms of biological and chemical drugs. The company concentrates on biochemical pharmaceuticals, and focuses on the market layout of R&D, production and sales of cardiovascular, cerebrovascular and digestive drugs. - The chemical drugs R&D platform, adopts a follower strategy, introduces the first generic or quick generic drugs of foreign expired and expiring patent medicines, and launches them in the domestic market.

 

 

  • 2010

    years

    Great Greatness was formally founded

  • 9700

    Ten thousand yuan

    Registered capital

  • 30+

    a

    New drugs in development

PRODUCT

CENTER

Jilin Province Great Great Pharmaceutical Co. LTD
imgboxbg

Broad Great Pharma

Maintain the health of the people


Polaprezine

Polaprezine is a complex compound formed by zinc and L-carnosine. Zinc is an ideal carrier for L-carnosine. The two produce a significant synergy.

Sodium Ferulate

Sodium ferulate is the sodium salt of ferulic acid, which is the main component of angelica sinensis, a traditional Chinese medicine for promoting blood circulation to remove blood stasis. The sodium ferulate injection compounded by using modern technology, not only retains the effect of promoting blood circulation to remove blood stasis of angelica sinensis, but gives a new connotation. The endothelin receptor antagonists are oxidation resistant, which can clear free radicals, and prevent platelet aggregation, with anti-inflammatory and immune adjustments, increasing blood creation function.

Neuropsychiatric Products

XY-AG: Originally developed by French Servier., it is the exclusive first generic product in China, and an antidepressant drug, which is a new breakthrough in the field of depression treatment (this variety has been declared to the SFDA for review). XY-TBZ: Originally developed by Janssen Pharmaceutical Ltd., it is a domestic clinical blockbuster drug for the treatment of epilepsy and migraine, with a unique mechanism of action.

Propyl Gallate

This product is a medicine with a stronger biological effect obtained by structural modification of the main active component - propyl gallate, on the basis of in-depth study of paeoniae radix rubra, a traditional Chinese medicine used for promoting blood circulation to remove blood stasis. This product can significantly inhibit platelet aggregation; enhance fibrinolytic activity, promote thrombolysis; reduce whole blood viscosity and plasma specific viscosity;

Anti-infection Products

XY-LN: Originally developed by Pfizer, it is the only drug for the treatment of vancomycin infection, which fills the gap in the few drugs that solve the clinical drug resistance problem (this variety has been declared to the SFDA for review).

Atrial Vessel Products

Innovation System R&D Capability Products under Research Scientific Research Cooperation

R&D

INNOVATION

Jilin Province Great Great Pharmaceutical Co. LTD
Innovation system
MORE 白箭头 黑箭头
Research and development ability
MORE 白箭头 黑箭头
In research products
MORE 白箭头 黑箭头
The scientific research cooperation
MORE 白箭头 黑箭头
Production management system
MORE 白箭头 黑箭头
Quality management system
MORE 白箭头 黑箭头

STYLE

CORPORATE

Jilin Province Great Great Pharmaceutical Co. LTD

HEALTH

SCIENCE

Jilin Province Great Great Pharmaceutical Co. LTD
Polyprezinc VS Rebamipide
Polyprezinc
Ruilaisheng | With its unique mechanism, can it be better?
Ruilaisheng
Relaisen-a new choice for eradicating Helicobacter pylori
Relaisen-a

NEWS

CENTER

Jilin Province Great Great Pharmaceutical Co. LTD
Liaoyuan City "Sika Deer + Medicine and Health" Industrial R&D Public Service Platform
十载悠悠岁月,一路筚路蓝缕,站在新的历史起点上的博大伟业,正以现代化企业的蓬勃朝气与家国担当践行药企人关注百姓健康增进民生福祉的使命初衷,发挥公共研发平台作用,共同托起辽源医药健康产业的美好未来。
Details 白箭头 黑箭头
Vice Governor Wang Tingkai and his party came to our company for investigation
Details 白箭头 黑箭头
Fraternity Club" -- To demonstrate corporate mission and responsibility in the face of the epidemic
Details 白箭头 黑箭头
Chai Wei, secretary of CPC Municipal Committee, visited our company to investigate the promotion of liaoyuan "Sika deer + medical and health industry"
With a deep concern for the liaoyuan medical and health industry, with the city of Liaoyuan "Sika deer + medical and health industry" a bright future. On the afternoon of September 16, more than 30 people, including Party secretary Chai Wei, Leaders Such as CAI Hongwei, Hu Yongwei, Tang Yan, Xu Hui, Chen Zhongliang and Zhang Fenglin, visited Broad Enterprise for investigation. Duan Chengjun, chairman of the board, introduced to the city leaders the development of our company in the past ten years, new product research and development, marketing and sales, platform construction, and the promotion of the "Sika deer + medical and health industry" work. In the past two years, our company has actively negotiated with the government of The Development zone and The Government of Liaoyuan city, negotiated with the academician workstation, adopted the government's promotion, academician's substantial participation, implemented the enterprise management, marketized operation mode, committed to the research and development and production of Sika deer products, and established Jilin Province Glast Biotechnology Co., LTD. The company has signed a cooperation agreement with academician workstation, and developed and produced series products such as deer antler health care products and food products by utilizing its technical resources, technical team and innovation achievements and relying on broad Cause's pilot test ability and industrial advantages.      Secretary wood to great achievements as the President unit of the medicine industry of jilin province technology innovation strategic alliance, promote union work and to undertake manufacture-learning-research cooperation with enterprise as the main body, the company has strong research and development ability and innovation ability to be fully recognized and high hopes and great play a leading role in industry, for Ming "sika deer + medicine health industry" stable healthy development contribution strength, instructs the staff service. Relevant leaders from the municipal Commission office, the Government office, the Political Research Office, the Development and Reform Commission, the Bureau of Science and Technology, the Bureau of Industry and Information Technology, the Bureau of Ecology and Environment, the Bureau of Commerce, the Federation of Industry and Commerce, the Tax bureau, the Bureau of Statistics, and the administrative Committee of the Development Zone accompanied the investigation.
Details 白箭头 黑箭头
The deputy director of the Provincial Department of Industry and Information Technology Mu Kezhen and his leaders came to our company for investigation
Braving the 35-degree heat and the coming heat wave, on the afternoon of July 23, mu Kezhen, deputy director of The Industry and Information Technology Department of The Province, Ma Guang, director of consumer goods Department of the Industry and Information Technology Department of the Province, Zhang Yinghong, director of the medical Department of the Industry and Information Technology Department of the Province and more than 10 people came to our company to investigate the production operation. Wu Shaohui, executive deputy general manager, introduced the development history and current production operation of our company in detail to the research group and answered their questions from time to time. The research group appreciated the achievements of our company in the past 10 years in the development, production and sales of cardiovascular and cerebrovascular, digestive, anti-cancer, neuropsychiatric drugs, which has been committed to the cause of human health and focused on biochemical pharmaceutical. Vice Director Mu Kezhen pointed out that in order to overcome the adverse impact of the epidemic, strengthen confidence in development, accurately grasp the new situation and new trends in the industry, enterprises should constantly strengthen their own technological transformation and innovation, and enhance their core competitiveness. All departments of the Provincial Department of Industry and Information Technology will earnestly enhance the sense of service, follow the front service, take the initiative, increase the support for enterprises from policy, technology, capital, talent and other aspects, create good conditions for the development of enterprises, promote the implementation of all policies to be detailed, and protect the healthy and rapid development of enterprises. Vice Mayor Xu Hui, Deputy secretary General Chen Zhongliang of the municipal Government, Director Zhu Yongku of the Municipal Industry and Information Technology Bureau and other officials accompanied the investigation.
Details 白箭头 黑箭头
Provincial drug administration service "two products and one device" enterprise development symposium was held in our company
Details 白箭头 黑箭头
Jilin Province Great Great Pharmaceutical Co. LTD

Service hotline

+86-431-81158731

CONTACT US

Jilin Province Great Great Pharmaceutical Co. LTD

Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD

Liaoyuan Production Base: No. 158 Fortune Road, Liaoyuan Economic Development Zone, Jilin Province

Tel:+86-437-6998023

Changchun R&D Center: No. 3786 Juye Street, Jingyue Development Zone, Changchun City, Jilin Province
Tel:+86-431-81158731(Marketing center)

Tel:+86-431-81158756(Research and development center)

Beijing Office: Room 901, Building F, Kaixuan City, 170 Beiyuan Road, Chaoyang District, Beijing
Tel:+86-10-58236233

Medication consultation, feedback on medication adverse reaction, and user complaint telephone:0437-5029815 

NO PUBLIC

Jilin Province Great Great Pharmaceutical Co. LTD

Scan and follow the official official account

Copyright © Jilin Province Great Great Pharmaceutical Co. LTD        吉ICP备20002630号

Website construction:300.cn Changchun   management     

Jilin Province Great Great Pharmaceutical Co. LTD